Latest News & Features
Americas
The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston. 6 May 2025
Americas
Decision follows director review ordered by Kathi Vidal two years ago | Two pieces of prior art successfully cited in arguments key to invalidation. 6 May 2025
Americas
The pharma giant and biopharma company Incyte announce settlement of dispute over alleged unpaid royalties | News comes on eve of trial in Manhattan. 6 May 2025
Americas
The team brings experience in Section 337 investigations, post-grant proceedings, and complex patent litigation in biopharmaceutical and medical device sectors. 6 May 2025
Europe
Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation. 2 May 2025
Americas
Latest report highlights increasing concerns over counterfeit pharmaceuticals, IP barriers, and market access challenges | Key countries to watch include India, China, the UAE, and Singapore | Report also outlines challenges in Mexico, Russia, Brazil, and Indonesia. 1 May 2025
Americas
Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity. 1 May 2025
Careers
The firm has rehired Kate Hillier as a partner in its Bay Area office, where she will advise public and private life sciences companies on strategic partnering, licensing and complex IP transactions. 1 May 2025
Europe
EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court had earlier overturned a first-instance decision allowing an injunction against Glenmark’s diabetes generic | AstraZeneca intends to appeal. 29 April 2025
Americas
Proposed patent legislation will save US innovation and counter the ‘existential threat’ that China poses to the West, hears Sarah Speight. 29 April 2025